1. The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer.
- Author
-
Lodewijk L, Willems SM, Dreijerink KMA, de Keizer B, van Diest PJ, Schepers A, Morreau H, Bonenkamp HJ, Van Engen-van Grunsven IACH, Kruijff S, van Hemel BM, Links TP, Nieveen van Dijkum E, van Eeden S, Valk GD, Borel Rinkes IHM, and Vriens MR
- Subjects
- Adult, Carcinoma, Neuroendocrine mortality, Carcinoma, Neuroendocrine secondary, Carcinoma, Neuroendocrine surgery, Databases, Factual, Female, Humans, Immunohistochemistry, Lymphatic Metastasis, Male, Microvessels pathology, Middle Aged, Molecular Imaging, Netherlands, Positron-Emission Tomography, Progression-Free Survival, Risk Assessment, Risk Factors, Thyroid Neoplasms mortality, Thyroid Neoplasms pathology, Thyroid Neoplasms surgery, Time Factors, Tissue Array Analysis, Antigens, Surface analysis, Biomarkers, Tumor analysis, Carcinoma, Neuroendocrine immunology, Glutamate Carboxypeptidase II analysis, Microvessels immunology, Theranostic Nanomedicine methods, Thyroid Neoplasms immunology
- Published
- 2018
- Full Text
- View/download PDF